Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 884546 SAN FRANCISCO, CA
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$30,520,300
+$4,396,855 QoQ
Shares Held
1,206,336
+2.8% QoQ
Ownership
0.700%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ACAD ranks #49 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in ACAD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,520,300 1,206,336
2026-03-31 $26,123,445 1,173,560
2025-12-31 $31,312,587 1,172,317
2025-09-30 $25,695,237 1,204,088
2025-06-30 $25,665,301 1,189,861
2025-03-31 $19,945,935 1,200,839
2024-12-31 $22,961,942 1,251,332
2024-09-30 $19,550,056 1,271,135
2024-06-30 $20,723,283 1,275,279
2024-03-31 $21,985,405 1,189,043
2023-12-31 $35,314,768 1,127,907
2023-09-30 $22,363,258 1,073,093
2023-06-30 $23,505,775 981,452
2023-03-31 $18,242,113 969,294
2022-12-31 $15,470,323 971,754
2022-09-30 $15,585,746 952,674
2022-06-30 $12,922,798 917,161
2022-03-31 $22,688,666 936,774
2021-12-31 $20,609,243 883,001
2021-09-30 $13,638,504 821,102
2021-06-30 $27,057,509 1,109,369
2021-03-31 $21,841,325 846,563
2020-12-31 $45,835,000 857,370
2020-09-30 $36,941,313 895,547
2020-06-30 $35,628,600 735,065
2020-03-31 $35,614,975 842,958